It could be that the upregulation of PPARγ inhibits the activation of NF-κB in a number of cell types including intestinal epithelial cells, macrophages and dendritic cells, thus preventing the production of pro-inflammatory cytokines that are involved in the pathology of IBD. This evidence concerns the gene PPARG and inflammatory bowel disease.